-
J.P. Morgan Remains Uncertain on PDL BioPharma
Thursday, November 11, 2010 - 10:36amIn a research report published by J.P. Morgan yesterday they reiterate their uncertainty toward PDL BioPharma (NasdaqGS: PDLI) due to OUS royalty disagreements. PDLI did receive their OUS royalty payment in August but J.P. Morgan feels payment expected at the end of November is uncertain. According...
Read More >> -
Oppenheimer's Current Biotech Ratings
Monday, September 13, 2010 - 10:41amStock Prices as of September 10, 2010 Anadys Pharmaceuticals Inc. (NASDAQ: ANDS) $1.75, PERFORM BioMarin Pharmaceutical (NASDAQ: BMRN) $22.62, PERFORM Chelsea Therapeutics (NASDAQ: CHTP) $3.91, PERFORM Dynavax Technologies (NASDAQ: DVAX) $1.69, PERFORM Genzyme (NASDAQ: GENZ) $70.63, PERFORM...
Read More >> -
Snap Commentaries From Oppenheimer
Thursday, September 2, 2010 - 11:02amOppenheimer published these commentaries focusing on energy, technology, healthcare, financial institutions, and consumer & business services. Energy: ExxonMobil Corporation (NYSE: XOM) expects natural gas prices in North American to remain depressed for the next two years, refining margins...
Read More >>
PDL Biopharma
From Benzinga's Newsdesk
- 07:02 AM The Buckle, Inc. Reports May 2012 Net Sales
- 07:02 AM Cato May Same-Store Sales Up 3%
- 07:01 AM Limited Brands May Sales up 6%
- 7:01 AM Ciena Reports Q2 EPS $0.04 vs $-0.02 Est; Revenues $477.6M vs $447.37M Est
- 07:01 AM Omeros Announces Initiation of Planned Pharmacokinetic Substudy in OMS302 Phase 3 Clinical Program
- 07:00 AM Cracker Barrel Announces Two New Directors Appointed to Board
- 07:00 AM Cracker Barrel Announces Two New Directors Appointed to Board
- 6:57 AM Morgan Stanley Initiates Coverage on Sandisk at Overweight, Announces PT of $45
- 6:56 AM Morgan Stanley Initiates Coverage on Intel at Underweight, Announces PT of $26
- 6:56 AM Bank of America Maintains Protective Life at Underperform, Raises PO from $29 to $31
- 06:55 AM ENGlobal Finalizes Credit Facility with PNC
- 6:55 AM Guggenheim Maintains Dollar General at Buy, Raises PT from $54 to $57
- 6:55 AM JP Morgan Maintains The Fresh Market at Overweight, Raises PT from $55 to $61
- 06:55 AM Graham Corporation Awarded $5 Million in Orders for Nuclear Energy Facilities and Oil Refinery in China
- 6:55 AM Bank of America Maintains Teavana Holdings at Neutral, Lowers PO from $25 to $16
Brain Trust
- The Buckle, Inc. Reports May 2012 Net Sales
- Cato May Same-Store Sales Up 3%
- Limited Brands May Sales up 6%
- Omeros Announces Initiation of Planned Pharmacokinetic Substudy in OMS302 Phase 3 Clinical Program
- Cracker Barrel Announces Two New Directors Appointed to Board
- Cracker Barrel Announces Two New Directors Appointed to Board
- ENGlobal Finalizes Credit Facility with PNC
- Graham Corporation Awarded $5 Million in Orders for Nuclear Energy Facilities and Oil Refinery in China
- UPDATE: Imperial Capital Initiates Orbital Sciences Corporation with Outperform, $19 PT on Lower R&D, Antares Rocket
- UPDATE: Imperial Capital Raises PT to $41 on Spirit Airlines on Positive Impact From Fuel Prices
- Is Facebook Secretly Cloning the iPhone 5?
- David Einhorn's Greenlight Capital Letter to Investors Defends Apple, Doesn't Mention Herbalife
- Was IBM Smart to Ban Siri?
- James Altucher Article Sends Neonode Soaring
- 5 Small-Cap Short Ideas
- Why Einhorn Is Wrong About Apple
- Facebook and Apple Together at Last?
- Meat Glue Harbors Rogue Diseases, Government Fails to Intervene
- Stocks to Watch for the All Things Digital Conference: AAPL, ORCL, P, LNKD, ZNGA
- Social Media Chatter on Dell Around Its Earnings Report
